TMEM63A inhibitors comprise a diverse array of chemical compounds that hinder the functional activity of TMEM63A through their influence on calcium signaling and homeostasis. Verapamil and diltiazem, as calcium channel blockers, reduce calcium entry into the cell, which can disrupt the internal calcium balance and consequently impact the functionality of TMEM63A, which is closely associated with calcium regulation. Similarly, 2-APB and thapsigargin target the endoplasmic reticulum's ability to store and release calcium, while ryanodine modifies ryanodine receptors, all of which are actions that can lead to alterations in calcium dynamics within the cell and subsequently diminish the activity of TMEM63A. SK&F 96365, by inhibiting receptor-mediated calcium entry and store-operated calcium channels, reduces intracellular calcium levels, further indirectly inhibiting TMEM63A activity. Gadolinium chloride and ruthenium red, known for their roles in blocking mechanosensitive and various calcium channels respectively, can also interfere with the activity of TMEM63A, potentially due to its mechanosensitive properties.
Continuing with this theme, nifedipine and amlodipine serve as dihydropyridine calcium channel blockers, which by limiting calcium influx, may indirectly suppress the activity of TMEM63A. The long-acting nature of amlodipine ensures sustained inhibition of calcium entry, providing a constant indirect inhibition of TMEM63A inhibitors. Carboxyeosin, by inhibiting plasma membrane Ca2+-ATPase, disrupts calcium extrusion and thus indirectly inhibits TMEM63A by affecting calcium balance within the cell. Bepridil, which has the unique ability to block both calcium and sodium channels, may further influence the ionic environment that TMEM63A is involved in maintaining, leading to its indirect inhibition. Collectively, these chemicals, through their targeted actions on calcium-related pathways and ion homeostasis, serve as inhibitors that can diminish the activity of TMEM63A without directly affecting its expression or function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
Verapamil is a calcium channel blocker that inhibits calcium influx. TMEM63A is associated with calcium homeostasis and may be indirectly inhibited by altered intracellular calcium levels due to verapamil. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem, another calcium channel blocker, decreases calcium entry into cells. This alteration in calcium dynamics can indirectly diminish TMEM63A function by modulating calcium-dependent signaling pathways. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-APB is an inhibitor of IP3 receptors and store-operated calcium channels, potentially affecting the calcium stores in the endoplasmic reticulum. Reduced ER calcium release may indirectly inhibit TMEM63A function. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that depletes calcium stores from the endoplasmic reticulum, potentially impacting TMEM63A activity through altered calcium homeostasis. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $219.00 $765.00 | 19 | |
Ryanodine selectively binds and alters the conformation of ryanodine receptors, influencing calcium release from sarcoplasmic/endoplasmic reticulum, which could indirectly affect TMEM63A activity. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $101.00 $155.00 $389.00 $643.00 | 2 | |
SK&F 96365 is a blocker of receptor-mediated calcium entry and store-operated calcium channels. This can lead to decreased intracellular calcium levels, indirectly diminishing TMEM63A activity. | ||||||
Gadolinium(III) chloride | 10138-52-0 | sc-224004 sc-224004A | 5 g 25 g | $150.00 $350.00 | 4 | |
Gadolinium chloride is known to inhibit stretch-activated ion channels. Since TMEM63A may be mechanosensitive, its activity could be indirectly inhibited by gadolinium chloride. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $184.00 $245.00 | 13 | |
Ruthenium red is an inhibitor of calcium uptake into mitochondria and various calcium channels. Its effect on calcium homeostasis can lead to an indirect diminishment of TMEM63A function. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $58.00 $170.00 | 15 | |
Nifedipine is a dihydropyridine calcium channel blocker that reduces calcium influx, which can indirectly inhibit TMEM63A activity by affecting calcium signaling pathways. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $73.00 $163.00 | 2 | |
Amlodipine is a long-acting calcium channel blocker, which by reducing calcium entry, can indirectly inhibit TMEM63A activity through modulation of calcium-dependent processes. |